Del Sette Capital Management LLC Makes New $1.25 Million Investment in DaVita Inc. (NYSE:DVA)

Del Sette Capital Management LLC acquired a new stake in DaVita Inc. (NYSE:DVA - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 8,386 shares of the company's stock, valued at approximately $1,254,000. DaVita makes up about 1.0% of Del Sette Capital Management LLC's holdings, making the stock its 25th biggest position.

Several other large investors have also recently added to or reduced their stakes in the company. SBI Securities Co. Ltd. acquired a new position in shares of DaVita in the fourth quarter valued at about $41,000. Quarry LP bought a new stake in DaVita in the 3rd quarter valued at about $60,000. Venturi Wealth Management LLC grew its position in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock worth $61,000 after purchasing an additional 152 shares in the last quarter. Versant Capital Management Inc increased its holdings in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $68,000 after purchasing an additional 169 shares during the period. Finally, Blue Trust Inc. raised its position in shares of DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after buying an additional 131 shares in the last quarter. Institutional investors own 90.12% of the company's stock.

DaVita Price Performance

Shares of DVA stock traded up $1.36 on Thursday, reaching $152.73. The company had a trading volume of 410,680 shares, compared to its average volume of 785,575. The stock has a market capitalization of $12.22 billion, a PE ratio of 14.22, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.18. The business's 50-day moving average is $157.71 and its 200 day moving average is $157.50. DaVita Inc. has a one year low of $125.64 and a one year high of $179.60.

Remove Ads

DaVita (NYSE:DVA - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities research analysts forecast that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have commented on DVA. StockNews.com lowered DaVita from a "buy" rating to a "hold" rating in a research note on Friday, March 21st. Barclays boosted their price target on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 18th. Cowen reiterated a "hold" rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research report on Friday, February 21st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company's stock. According to MarketBeat, DaVita has a consensus rating of "Hold" and an average price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.